{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:54:07Z","timestamp":1791536047043,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH201"],"award-info":[{"award-number":["ZR2022QH201"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024MC119"],"award-info":[{"award-number":["ZR2024MC119"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR202111120048"],"award-info":[{"award-number":["ZR202111120048"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32300788"],"award-info":[{"award-number":["32300788"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2025.149426","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:15:44Z","timestamp":1764720944000},"page":"149426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["Antibody-based targeted protein degradation: Mechanisms, challenges and future directions"],"prefix":"10.1016","volume":"337","author":[{"given":"Yujing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanpeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzheng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149426_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"32","key":"10.1016\/j.ijbiomac.2025.149426_bb0010","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1039\/D3SC02361C","article-title":"Opportunities and challenges of protein-based targeted protein degradation","volume":"14","author":"Shen","year":"2023","journal-title":"Chem. Sci."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.149426_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202500184","article-title":"Development of antibody-based strategies for targeted degradation of membrane and extracellular proteins","volume":"26","author":"Sun","year":"2025","journal-title":"Chembiochem"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149426_bb0020","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1021\/acs.bioconjchem.9b00025","article-title":"Antibody delivery for intracellular targets: emergent therapeutic potential","volume":"30","author":"Singh","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149426_bb0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40824-023-00385-8","article-title":"Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)","volume":"27","author":"Wang","year":"2023","journal-title":"Biomater. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149426_bb0030","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.cell.2017.10.033","article-title":"A method for the acute and rapid degradation of endogenous proteins","volume":"171","author":"Clift","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149426_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149426_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41580-019-0185-4","article-title":"Lysosomes as dynamic regulators of cell and organismal homeostasis","volume":"21","author":"Ballabio","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.149426_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15314","article-title":"Engineered clearing agents for the selective depletion of antigen-specific antibodies","volume":"8","author":"Devanaboyina","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149426_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063236","article-title":"Engineered monoclonal antibody with novel antigen-sweeping activity in vivo","volume":"8","author":"Igawa","year":"2013","journal-title":"PLoS One"},{"issue":"7820","key":"10.1016\/j.ijbiomac.2025.149426_bb0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149426_bb0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/jacs.0c10008","article-title":"Development of antibody-based PROTACs for the degradation of the cell-surface immune checkpoint protein PD-L1","volume":"143","author":"Cotton","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"40","key":"10.1016\/j.ijbiomac.2025.149426_bb0065","doi-asserted-by":"crossref","first-page":"16377","DOI":"10.1021\/jacs.1c08521","article-title":"Covalently engineered nanobody chimeras for targeted membrane protein degradation","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149426_bb0070","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.37349\/etat.2023.00194","article-title":"Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy","volume":"4","author":"Joshi","year":"2023","journal-title":"Explor. Target. Antitumor Ther."},{"issue":"46","key":"10.1016\/j.ijbiomac.2025.149426_bb0075","doi-asserted-by":"crossref","first-page":"19985","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"107","author":"Mallery","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149426_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13059-019-1624-4","article-title":"Degradation of endogenous proteins and generation of a null-like phenotype in zebrafish using Trim-Away technology","volume":"20","author":"Chen","year":"2019","journal-title":"Genome Biol."},{"issue":"7834","key":"10.1016\/j.ijbiomac.2025.149426_bb0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2759-x","article-title":"Initiation of a conserved trophectoderm program in human, cow and mouse embryos","volume":"587","author":"Gerri","year":"2020","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.149426_bb0090","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1080\/15384101.2019.1661173","article-title":"Loss of CENPF leads to developmental failure in mouse embryos","volume":"18","author":"Zhou","year":"2019","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149426_bb0095","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/biolre\/ioz106","article-title":"SNAP23 is required for constitutive and regulated exocytosis in mouse oocytesdagger","volume":"101","author":"Mehlmann","year":"2019","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ijbiomac.2025.149426_bb0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.semcdb.2021.09.012","article-title":"Targeted protein degradation using intracellular antibodies and its application to neurodegenerative disease","volume":"126","author":"Benn","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2025.149426_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ydbio.2020.10.014","article-title":"Trim-Away mediated knock down uncovers a new function for Lbh during gastrulation of Xenopus laevis","volume":"470","author":"Weir","year":"2021","journal-title":"Dev. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.149426_bb0110","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/s41596-018-0028-3","article-title":"Acute and rapid degradation of endogenous proteins by Trim-Away","volume":"13","author":"Clift","year":"2018","journal-title":"Nat. Protoc."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.149426_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101512","article-title":"A promising intracellular protein-degradation strategy: TRIMbody-away technique based on nanobody fragment","volume":"11","author":"Chen","year":"2021","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149426_bb0120","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1021\/acscentsci.2c00998","article-title":"A cell-permeant nanobody-based degrader that induces fetal hemoglobin","volume":"8","author":"Shen","year":"2022","journal-title":"ACS Cent. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149426_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218959120","article-title":"Evolution of nanobodies specific for BCL11A","volume":"120","author":"Yin","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149426_bb0130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s13402-022-00693-6","article-title":"Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer","volume":"45","author":"Dey","year":"2022","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149426_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106307","article-title":"An AKT1-and TRIM21-mediated phosphodegron controls proteasomal degradation of HuR enabling cell survival under heat shock","volume":"26","author":"Nag","year":"2023","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149426_bb0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.dmpk.2015.12.007","article-title":"PK\/PD analysis of a novel pH-dependent antigen-binding antibody using a dynamic antibody-antigen binding model","volume":"31","author":"Haraya","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149426_bb0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imr.12392","article-title":"Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation","volume":"270","author":"Igawa","year":"2016","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149426_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9586","article-title":"Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses","volume":"5","author":"Blumberg","year":"2019","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.149426_bb0155","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.tips.2018.07.007","article-title":"Targeting FcRn to generate antibody-based therapeutics","volume":"39","author":"Ward","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.149426_bb0160","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.bbapap.2014.08.003","article-title":"pH-dependent antigen-binding antibodies as a novel therapeutic modality","volume":"1844","author":"Igawa","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.149426_bb0165","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nbt.1691","article-title":"Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization","volume":"28","author":"Igawa","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149426_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209509","article-title":"Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody","volume":"13","author":"Sampei","year":"2018","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.149426_bb0175","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s40265-020-01380-2","article-title":"Satralizumab: first approval","volume":"80","author":"Heo","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149426_bb0180","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jaci.2020.08.028","article-title":"ARGX-117, a therapeutic complement inhibiting antibody targeting C2","volume":"147","author":"Van de Walle","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149426_bb0185","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1038\/s41467-025-62925-1","article-title":"Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart","volume":"16","author":"Van de Walle","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149426_bb0190","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/s41598-021-81669-8","article-title":"Novel myostatin-specific antibody enhances muscle strength in muscle disease models","volume":"11","author":"Muramatsu","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149426_bb0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2131\/jts.48.399","article-title":"Preclinical in vitro evaluation of immune suppression induced by GYM329, Fc-engineered sweeping antibody","volume":"48","author":"Iwata","year":"2023","journal-title":"J. Toxicol. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.149426_bb0200","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/nbt1143","article-title":"Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels","volume":"23","author":"Vaccaro","year":"2005","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149426_bb0205","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1073\/pnas.0708960105","article-title":"Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn","volume":"105","author":"Mezo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149426_bb0210","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jaci.2011.11.029","article-title":"Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcgammaRIIb with Fc-engineered antibody","volume":"129","author":"Chu","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149426_bb0215","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.chembiol.2021.02.024","article-title":"Degradation from the outside in: targeting extracellular and membrane proteins for degradation through the endolysosomal pathway","volume":"28","author":"Ahn","year":"2021","journal-title":"Cell Chem. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149426_bb0220","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4049\/jimmunol.1003780","article-title":"Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model","volume":"187","author":"Patel","year":"2011","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149426_bb0225","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.ymthe.2020.11.017","article-title":"Selective depletion of antigen-specific antibodies for the treatment of demyelinating disease","volume":"29","author":"Sun","year":"2021","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149426_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1976705","article-title":"Selective depletion of radiolabeled HER2-specific antibody for contrast improvement during PET","volume":"13","author":"Khare","year":"2021","journal-title":"MAbs"},{"issue":"6668","key":"10.1016\/j.ijbiomac.2025.149426_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf6249","article-title":"Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras","volume":"382","author":"Ahn","year":"2023","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149426_bb0240","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/acscentsci.1c00146","article-title":"Development of triantennary N-acetylgalactosamine conjugates as degraders for extracellular proteins","volume":"7","author":"Zhou","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149426_bb0245","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41589-021-00851-1","article-title":"Bifunctional small molecules that mediate the degradation of extracellular proteins","volume":"17","author":"Caianiello","year":"2021","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149426_bb0250","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","article-title":"LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation","volume":"17","author":"Ahn","year":"2021","journal-title":"Nat. Chem. Biol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.149426_bb0255","article-title":"Aptamer-LYTACs for targeted degradation of extracellular and membrane proteins","volume":"62","author":"Wu","year":"2023","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149426_bb0260","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.chembiol.2024.01.002","article-title":"Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor","volume":"31","author":"Su","year":"2024","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149426_bb0265","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41467-025-56648-6","article-title":"A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy","volume":"16","author":"Xiao","year":"2025","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.149426_bb0270","article-title":"Dendronized DNA chimeras harness scavenger receptors to degrade cell membrane proteins","volume":"62","author":"Zhu","year":"2023","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149426_bb0275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41587-022-01456-2","article-title":"Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins","volume":"41","author":"Pance","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149426_bb0280","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/acschembio.2c00185","article-title":"Roadmap for optimizing and broadening antibody-based PROTACs for degradation of cell surface proteins","volume":"17","author":"Gramespacher","year":"2022","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149426_bb0285","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41589-024-01803-1","article-title":"Chemically engineered antibodies for autophagy-based receptor degradation","volume":"21","author":"Cheng","year":"2025","journal-title":"Nat. Chem. Biol."},{"issue":"7930","key":"10.1016\/j.ijbiomac.2025.149426_bb0290","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-022-05235-6","article-title":"Antibody targeting of E3 ubiquitin ligases for receptor degradation","volume":"610","author":"Marei","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149426_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004225","article-title":"Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology","volume":"10","author":"Zhou","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"48","key":"10.1016\/j.ijbiomac.2025.149426_bb0300","doi-asserted-by":"crossref","first-page":"32933","DOI":"10.1021\/jacs.4c06160","article-title":"Conditionally activatable chimeras for tumor-specific membrane protein degradation","volume":"146","author":"Liu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2025.149426_bb0305","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.actbio.2025.08.030","article-title":"A viral infection-biomimetic strategy for antibody-guided targeted protein degradation","volume":"205","author":"Yang","year":"2025","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.149426_bb0310","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41577-025-01207-9","article-title":"Fifty years of monoclonals: the past, present and future of antibody therapeutics","volume":"25","author":"Chan","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149426_bb0315","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1038\/s41467-025-61272-5","article-title":"SE(3)-equivariant ternary complex prediction towards target protein degradation","volume":"16","author":"Fanglei","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.149426_bb0320","first-page":"100121","article-title":"Explainable artificial intelligence for targeted protein degradation predictions","volume":"7","author":"Prael","year":"2024","journal-title":"Artif. Intell. Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.149426_bb0325","first-page":"5323-5323","article-title":"Abstract 5323: accelerating the drug discovery process with an automated high-throughput protein production and characterization platform for AI-driven antibody development of immunotherapy","volume":"83","author":"Zhehao","year":"2023","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149426_bb0330","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1038\/s41401-024-01266-z","article-title":"Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy","volume":"45","author":"Zhifeng","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"8051","key":"10.1016\/j.ijbiomac.2025.149426_bb0335","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41586-024-07948-2","article-title":"Designed endocytosis-inducing proteins degrade targets and amplify signals","volume":"638","author":"Huang","year":"2025","journal-title":"Nature"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025099830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025099830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:52:25Z","timestamp":1768942345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025099830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":67,"alternative-id":["S0141813025099830"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149426","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-based targeted protein degradation: Mechanisms, challenges and future directions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149426"}}